Chronic Fatigue Syndrome Pathophysiology and Treatment (R01) | Apply Online

Opportunity Summary:

The NIH funding opportunity PA 08 246, titled "Chronic Fatigue Syndrome Pathophysiology and Treatment (R01)," is a discretionary research grant announcement led by the Office of Research on Women's Health (ORWH) with multiple co-sponsoring NIH Institutes and Centers. Its core aim is to support investigator-initiated research that deepens scientific understanding of chronic fatigue syndrome, also known as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), with an emphasis on studies that can clarify what causes the illness, how it develops in the body, how it can be diagnosed more accurately, and how it can be treated more effectively. A key theme throughout the announcement is that ME/CFS affects multiple body systems and presents differently across individuals, so proposals that seriously grapple with complexity, variability, and real-world patient diversity are especially encouraged.

The FOA invites projects that examine ME/CFS across the lifespan and in diverse populations, reflecting NIH interest in understanding how age, sex, gender-related factors, comorbidities, and other demographic or social determinants may shape risk, presentation, and outcomes. The opportunity specifically highlights the value of innovative research that addresses gaps in knowledge about environmental and biological risk factors, including how exposures or triggers might interact with physiological systems. It also calls attention to the problem of heterogeneity among patient populations, meaning that different subgroups of patients may have different underlying mechanisms or clinical trajectories; applications that propose ways to identify, explain, or stratify these differences fit well with the intent of the announcement. Another stated priority is research into common mechanisms that may link the multiple affected systems in ME/CFS, supporting integrative approaches that connect, for example, neurological, immune, endocrine, metabolic, autonomic, infectious, or other pathways in a coherent disease model.

NIH signals a strong preference for interdisciplinary research, meaning projects that bring together expertise across fields rather than staying confined within a single discipline. The goal is not only to produce basic insights about disease processes, but also to move toward evidence-based solutions that improve diagnosis, treatment, and overall quality of life for people living with ME/CFS. In practice, this can include studies that propose and test clinical interventions, develop or validate diagnostic approaches, or map pathophysiological pathways in ways that lead directly to actionable clinical strategies. While the announcement does not mandate particular study designs in the summary provided, the emphasis on etiology, diagnosis, pathophysiology, and treatment suggests that both mechanistic and translational/clinical projects are within scope, provided they are rigorous and clearly tied to advancing care and understanding.

From a grants mechanism standpoint, this FOA uses the NIH Research Project Grant (R01) mechanism, which is typically intended for more mature, hypothesis-driven projects with a well-developed approach and sufficient preliminary basis to justify a multi-year plan. The announcement notes that it runs in parallel with another FOA of identical scientific scope, PA 08 247, that uses the R21 exploratory/developmental mechanism. The practical takeaway is that applicants with early-stage, high-risk, or proof-of-concept ideas might consider the R21 route, while applicants ready for a larger, more definitive project would target this R01 FOA.

The project period under this opportunity may not exceed five years. Funding levels and the number of awards are not guaranteed; awards depend on the availability of funds and on receiving a sufficient number of applications judged to be meritorious through NIH peer review and funding decisions. The opportunity does not require cost sharing or matching funds, which reduces barriers for many applicants and aligns with standard NIH practice for research grants.

Eligibility is broad and includes many types of domestic and non-domestic organizations. Eligible applicants listed include public and private institutions of higher education, nonprofit organizations (both 501(c)(3) and non-501(c)(3) entities), for-profit organizations (including small businesses), state and local governments, U.S. territories or possessions, public housing authorities/Indian housing authorities, school districts, and various tribal governments and tribal organizations. The eligibility section further clarifies inclusion of organizations such as historically black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, faith-based or community-based organizations, eligible federal agencies, regional organizations, and foreign (non-U.S.) entities. This wide eligibility reflects NIH interest in building a diverse research ecosystem and enabling studies in different settings and populations.

Administratively, the opportunity is associated with multiple CFDA program areas spanning environmental health, neurosciences, immunology, microbiology and infectious diseases, aging, child health, nursing research, complementary and integrative health, and several disease-focused research programs, which underscores the cross-cutting nature of ME/CFS and the expectation that proposals may align with more than one biomedical domain. Key dates in the provided record include a posted date of August 21, 2008, with closing dates indicated as September 7, 2011 (original) and January 7, 2012 (current at the time), and an archive date of February 7, 2012, meaning it is no longer an active solicitation but remains useful as a reference for NIH priorities and historical program focus. The full archived announcement is linked through the NIH Grants Guide, and technical access issues are directed to the NIH Office of Extramural Research (OER) webmaster contact listed in the notice.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Environment Health Income Security and Social Services

Next opportunity: Chronic Fatigue Syndrome Pathophysiology and Treatment (R21)

Previous opportunity: Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 08 246

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 08 246) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 08 246", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.